TPU PHARMA - Trademark Details
Status: 748 - Statement Of Use - To Examiner
Serial Number
90980667
Word Mark
TPU PHARMA
Status
748 - Statement Of Use - To Examiner
Status Date
2023-12-01
Filing Date
2020-10-12
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-03-23
Attorney Name
Law Office Assigned Location Code
O20
Employee Name
HSU, FONG
Statements
Disclaimer with Predetermined Text
"PHARMA"
Goods and Services
Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical products, namely, analgesics
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-11-28
Primary Code
005
First Use Anywhere Date
2023-11-13
First Use In Commerce Date
2023-11-13
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Bret E. Field
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Continuity Parent | 90248758 |
Trademark Events
| Event Date | Event Description |
| 2020-10-15 | NEW APPLICATION ENTERED |
| 2020-11-28 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2021-01-08 | ASSIGNED TO EXAMINER |
| 2021-01-13 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-01-13 | EXAMINERS AMENDMENT E-MAILED |
| 2021-01-13 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-01-14 | ASSIGNED TO LIE |
| 2021-01-14 | EXAMINER'S AMENDMENT ENTERED |
| 2021-01-15 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-02-02 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| 2021-02-06 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| 2021-02-16 | EXAMINERS AMENDMENT -WRITTEN |
| 2021-02-16 | EXAMINERS AMENDMENT E-MAILED |
| 2021-02-16 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2021-02-16 | EXAMINER'S AMENDMENT ENTERED |
| 2021-02-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-03-03 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-03-23 | PUBLISHED FOR OPPOSITION |
| 2021-03-23 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-05-18 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2021-11-11 | SOU TEAS EXTENSION RECEIVED |
| 2021-11-11 | SOU EXTENSION 1 FILED |
| 2021-11-11 | SOU EXTENSION 1 GRANTED |
| 2021-11-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2022-05-16 | SOU TEAS EXTENSION RECEIVED |
| 2022-05-16 | SOU EXTENSION 2 FILED |
| 2022-05-16 | SOU EXTENSION 2 GRANTED |
| 2022-05-18 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2022-11-15 | SOU TEAS EXTENSION RECEIVED |
| 2022-11-15 | SOU EXTENSION 3 FILED |
| 2022-11-15 | SOU EXTENSION 3 GRANTED |
| 2022-11-17 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2023-05-09 | SOU TEAS EXTENSION RECEIVED |
| 2023-05-09 | SOU EXTENSION 4 FILED |
| 2023-05-09 | SOU EXTENSION 4 GRANTED |
| 2023-05-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2023-11-14 | TEAS STATEMENT OF USE RECEIVED |
| 2023-11-27 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2023-11-14 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2023-11-29 | DIVISIONAL REQUEST RECEIVED |
| 2023-12-01 | DIVISIONAL PROCESSING COMPLETE |
| 2023-11-14 | USE AMENDMENT FILED |
| 2023-12-01 | STATEMENT OF USE PROCESSING COMPLETE |
